0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Seroprevalence of Varicella Zoster Virus in the Eastern Province of Saudi Arabia in Post-vaccination Era

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background:

          Varicella zoster virus (VZV) is a highly contagious virus causing two types of skin infections known as varicella and herpes zoster. Due to its high burden, vaccination is available in almost 42 counties worldwide including Saudi Arabia. Since its introduction, data on the impact of the vaccine from local and neighboring countries is lacking.

          Objective:

          This study was done to determine the seroprevalence of anti VZV IgG and IgM antibodies in post-vaccination era fifteen years after varicella vaccine introduction in routine childhood vaccination schedules.

          Methods:

          retrospective observational study over seven years on all individual tested for anti VZV IgG and IgM in a tertiary university hospital in the eastern province of Saudi Arabia between Jan 2014 to Dec 2020.

          Results:

          83.69% (6820/8149) of tested population were seropositive with significantly lower positivity in children less than ten years old (44%). Yet no significant difference was found between males and females or among different nationalities tested. Conclusions: varicella continuous to be prevalent in the eastern province of Saudi Arabia fifteen years after the introduction of the vaccine but the level of anti VZV IgG detection is significantly lower in children below ten years of age. Further large-scale studies are needed to assess the impact of universal vaccination on the epidemiology of VZV.

          Related collections

          Most cited references29

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Clinical Features of Varicella-Zoster Virus Infection

          Varicella-zoster virus (VZV) is a pathogenic human herpes virus that causes varicella (chickenpox) as a primary infection, following which it becomes latent in peripheral ganglia. Decades later, the virus may reactivate either spontaneously or after a number of triggering factors to cause herpes zoster (shingles). Varicella and its complications are more severe in the immunosuppressed. The most frequent and important complication of VZV reactivation is postherpetic neuralgia, the cause of which is unknown and for which treatment is usually ineffective. Reactivation of VZV may also cause a wide variety of neurological syndromes, the most significant of which is a vasculitis, which is treated with corticosteroids and the antiviral drug acyclovir. Other VZV reactivation complications include an encephalitis, segmental motor weakness and myelopathy, cranial neuropathies, Guillain–Barré syndrome, enteric features, and zoster sine herpete, in which the viral reactivation occurs in the absence of the characteristic dermatomally distributed vesicular rash of herpes zoster. There has also been a recent association of VZV with giant cell arteritis and this interesting finding needs further corroboration. Vaccination is now available for the prevention of both varicella in children and herpes zoster in older individuals.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Increasing Incidence of Herpes Zoster Over a 60-year Period From a Population-based Study.

            Temporal increases in the incidence of herpes zoster (HZ) have been reported but studies have examined short study periods, and the cause of the increase remains unknown. We examined the long-term trend of HZ.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Global impact of varicella vaccination programs

              Although varicella is usually a mild and self-limited disease, complications can occur. In 1998, the World Health Organization recommended varicella vaccination for countries where the disease has a significant public health burden. Nonetheless, concerns about a shift in the disease to older groups, an increase in herpes zoster in the elderly and cost-effectiveness led many countries to postpone universal varicella vaccine introduction. In this review, we summarize the accumulating evidence, available mostly from high and middle-income countries supporting a high impact of universal vaccination in reductions of the incidence of the disease and hospitalizations and its cost-effectiveness. We have also observed the effect of herd immunity and noted that there is no definitive and consistent association between vaccination and the increase in herpes zoster incidence in the elderly.
                Bookmark

                Author and article information

                Journal
                Med Arch
                Med Arch
                Medical Archives
                Medical Archives
                Academy of Medical Sciences of Bosnia and Herzegovina
                0350-199X
                1986-5961
                2023
                : 77
                : 5
                : 358-362
                Affiliations
                Department of Microbiology, Collage of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia
                Author notes
                Corresponding author: Reem Al Dossary, PhD, Imam Abdulrahman Bin Faisal University, Dammam 31441, 35155 raaldossary@ 123456iau.edu.sa ORCID ID: http//www.orcid.org/0000-0002-5255-5222
                Article
                10.5455/medarh.2023.77.358-362
                10825756
                38299088
                bdf8eac3-e84b-4c79-a8b5-810316733178
                © 2023 Reem Al Dossary

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 06 September 2023
                : 14 October 2023
                Categories
                Original Paper

                varicella zoster virus (vzv),igg,igm,seroprevalence
                varicella zoster virus (vzv), igg, igm, seroprevalence

                Comments

                Comment on this article